META-2i

N/A

Report date: 2023/12/22 16:52:08
NMEFirst In Class

Base Information

Drug NameMETA-2i
Drug Alias NameMETA-02META-002META-2i
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsHypercholesterolemiaHyperlipidemiasMetabolic Dysfunction-Associated Steatotic Liver Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesMeta Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesMeta Pharmaceuticals IncXtalPi Inc
Inactive CompaniesN/A
Active IndicationsHypercholesterolemiaHyperlipidemiasMetabolic Dysfunction-Associated Steatotic Liver Disease
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A